A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

BACKGROUND: This study was designed to compare cisplatin/docetaxel with oxaliplatin/docetaxel in patients with advanced and metastatic non-small lung cancer as a first-line treatment. METHODS: Patients were randomly assigned to receive either cisplatin 75 mg m(−2) and docetaxel 75 mg m(−2) every 3 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Atmaca, A, Al-Batran, S-E, Werner, D, Pauligk, C, Güner, T, Koepke, A, Bernhard, H, Wenzel, T, Banat, A-G, Brueck, P, Caca, K, Prasnikar, N, Kullmann, F, Günther Derigs, H, Koenigsmann, M, Dingeldein, G, Neuhaus, T, Jäger, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566804/
https://www.ncbi.nlm.nih.gov/pubmed/23329236
http://dx.doi.org/10.1038/bjc.2012.555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566804/
https://www.ncbi.nlm.nih.gov/pubmed/23329236
http://dx.doi.org/10.1038/bjc.2012.555

Ejemplares similares